Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy

American Heart Journal

Volumn 118, Issue 3, 1989, Pages 520-525

  Ganguly, Pallab K ^a,b   Lee, Sheu L ^a,b   Beamish, Robert E ^a,b   Dhalla, Naranjan S ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR;

ANIMAL EXPERIMENT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE TISSUE LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CARDIOMEGALY; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; HEART; MALE; MYOCARDIUM; NOREPINEPHRINE; RATS; RATS, INBRED STRAINS; RECEPTORS, ADRENERGIC; RNA; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM;

EID: 0024453362     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(89)90267-6     Document Type: Article

References (32)

1. Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy
2. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog
3. Pathogenesis of cardiac hypertrophy in iron deficiency anaemia: the role of noradrenaline
4. Norepinephrine—the myocardial hypertrophy hormone?
5. 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating
6. Norepinephrine induced cardiac hypertrophy in dogs
7. Sympathetic changes during development of cardiac hypertrophy in aortic—constricted rats
8. Norepinephrine metabolism in hypertrophied rat hearts
9. Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy
10. Norepinephrine turnover in the heart and blood vessels of rats subjected to bilateral renal infarction
11. Beneficial effects of verapamil in diabetic cardiomyopathy
12. Norepinephrine storage distribution and release in diabetic cardiomyopathy
13. Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy
14. A sensitive enzymatic assay for dopamine-β-hydroxylase
15. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts
16. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
17. Protein measurements with the Folin phenol reagent
18. The attractions of proteins for small molecules and ions
19. Biochemical correlates of cardiac hypertrophy. I. Experimental model; changes in heart weight, RNA content and nuclear RNA polymerase activity
20. Chronic norepinephrine infusion and adrenergic function of hypertrophied hearts
21. Experimental diabetes: alterations in circulating dopamine-β-hydoxylase and norepinephrine
22. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure
23. Modulation of sympathetic transmission by neuronally released dopamine
24. Norepinephrine stores in the hypertrophied bovine heart
25. The effect of iron deficiency anaemia in the rat on catecholamine levels and morphology
26. Cardiac norepinephrine store and the contractile state of heart muscle
27. Role of adrenergic mechanisms in the development of cardiac hypertrophy
28. Norepinephrine increases β-receptors and adenylate cyclase in canine myocardium
29. Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism
30. 1 adrenergic response
31. Transformation of adrenergic receptors in the myocardium
32. Does norepinephrine play a central causative role in the process of cardiac hypertrophy?